A subset of ER+/HER2− BC contains a dense lymphocytic infiltration, similar to that seen in TNBC12,13; however, it is unclear how this relates to the response to immune checkpoint inhibitors in ER+/HER2− BC14–16. Here, ESR1 is linked to breast cancer.